Cited by

• Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications.

  Song Y, Bienvenu LA, Bongcaron V, Prijaya SA, Maluenda AC, Walsh APG, McFayden JD, Pietersz GA, Peter K, Wang X. Song Y, et al. Theranostics. 2024 May 19;14(8):3267-3281. doi: 10.7150/thno.97517. eCollection 2024. Theranostics. 2024. PMID: 38855181 Free PMC article.
• Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy.

  Berteotti M, Gori AM, Giusti B, Fortini A, Grossi G, Ciardetti N, Migliorini A, Lotti E, Valenti R, Di Mario C, Marchionni N, Marcucci R. Berteotti M, et al. J Thromb Thrombolysis. 2023 May;55(4):667-679. doi: 10.1007/s11239-023-02784-z. Epub 2023 Mar 11. J Thromb Thrombolysis. 2023. PMID: 36905562 Free PMC article.
• Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: a longitudinal cohort study.

  Lee CC, Chang CH, Hung Y, Lin CS, Yang SP, Cheng SM, Yu FH, Lin WS, Lin WY. Lee CC, et al. Thromb J. 2021 Dec 14;19(1):100. doi: 10.1186/s12959-021-00353-z. Thromb J. 2021. PMID: 34906162 Free PMC article.
• Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.

  Smits PC, Frigoli E, Tijssen J, Jüni P, Vranckx P, Ozaki Y, Morice MC, Chevalier B, Onuma Y, Windecker S, Tonino PAL, Roffi M, Lesiak M, Mahfoud F, Bartunek J, Hildick-Smith D, Colombo A, Stankovic G, Iñiguez A, Schultz C, Kornowski R, Ong PJL, Alasnag M, Rodriguez AE, Moschovitis A, Laanmets P, Heg D, Valgimigli M; MASTER DAPT Investigators. Smits PC, et al. Circulation. 2021 Oct 12;144(15):1196-1211. doi: 10.1161/CIRCULATIONAHA.121.056680. Epub 2021 Aug 29. Circulation. 2021. PMID: 34455849 Free PMC article. Clinical Trial.
• Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention.

  Kwak S, Yang HM. Kwak S, et al. J Lipid Atheroscler. 2019 May;8(1):8-14. doi: 10.12997/jla.2019.8.1.8. Epub 2019 May 10. J Lipid Atheroscler. 2019. PMID: 32821695 Free PMC article. Review.